These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 29769344)

  • 1. Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors.
    Kiener R; Fleischmann M; Wiegand MA; Lemmermann NAW; Schwegler C; Kaufmann C; Renzaho A; Thomas S; Felder E; Niller HH; Asbach B; Wagner R
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29769344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
    Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionally inactivated dominant viral antigens of human cytomegalovirus delivered in replication incompetent adenovirus type 6 vectors as vaccine candidates.
    Tang A; Freed DC; Li F; Meschino S; Prokop M; Bett A; Casimiro D; Wang D; Fu TM
    Hum Vaccin Immunother; 2017 Dec; 13(12):2763-2771. PubMed ID: 28494195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
    Lilja AE; Mason PW
    Vaccine; 2012 Nov; 30(49):6980-90. PubMed ID: 23041121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells.
    Link EK; Brandmüller C; Suezer Y; Ameres S; Volz A; Moosmann A; Sutter G; Lehmann MH
    Vaccine; 2017 Sep; 35(38):5131-5139. PubMed ID: 28818566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice.
    Lenfant F; Pizzato N; Liang S; Davrinche C; Le Bouteiller P; Horuzsko A
    J Gen Virol; 2003 Feb; 84(Pt 2):307-317. PubMed ID: 12560562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.
    Schleiss MR; Berka U; Watson E; Aistleithner M; Kiefmann B; Mangeat B; Swanson EC; Gillis PA; Hernandez-Alvarado N; Fernández-Alarcón C; Zabeli JC; Pinschewer DD; Lilja AE; Schwendinger M; Guirakhoo F; Monath TP; Orlinger KK
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction and transfection of eucaryotic expression recombinant vector containing truncated region of UL83 gene of human cytomegalovirus and it's sheltered effect as DNA vaccine].
    Gao RB; Li YQ; Wang ML
    Wei Sheng Wu Xue Bao; 2006 Jun; 46(3):451-5. PubMed ID: 16933619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z; Moutaftsi M; Borysiewicz LK
    J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo.
    Kiener R; Fleischmann M; Schwegler C; Ruzsics Z; Thirion C; Schrödel S; Asbach B; Wagner R
    Sci Rep; 2018 Jan; 8(1):1474. PubMed ID: 29367743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic monitoring of viral gene expression reveals rapid antiviral effects of CD8 T cells recognizing the HCMV-pp65 antigen.
    Khan F; Müller TR; Kasmapour B; Ynga-Durand MA; Eiz-Vesper B; von Einem J; Busch DH; Cicin-Sain L
    Front Immunol; 2024; 15():1439184. PubMed ID: 39104541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
    Morello CS; Cranmer LD; Spector DH
    J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients.
    Lilleri D; Zelini P; Fornara C; Comolli G; Gerna G
    Am J Transplant; 2007 Aug; 7(8):1997-2005. PubMed ID: 17617865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65).
    Yue Y; Kaur A; Zhou SS; Barry PA
    J Gen Virol; 2006 Apr; 87(Pt 4):777-787. PubMed ID: 16528025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.
    Cardin RD; Bravo FJ; Pullum DA; Orlinger K; Watson EM; Aspoeck A; Fuhrmann G; Guirakhoo F; Monath T; Bernstein DI
    Vaccine; 2016 Apr; 34(17):1993-9. PubMed ID: 26973071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized recombinant dense bodies of human cytomegalovirus efficiently prime virus specific lymphocytes and neutralizing antibodies without the addition of adjuvant.
    Becke S; Aue S; Thomas D; Schader S; Podlech J; Bopp T; Sedmak T; Wolfrum U; Plachter B; Reyda S
    Vaccine; 2010 Aug; 28(38):6191-8. PubMed ID: 20655401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells.
    Arrode G; Boccaccio C; Abastado JP; Davrinche C
    J Virol; 2002 Jan; 76(1):142-50. PubMed ID: 11739680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.
    Daenthanasanmak A; Salguero G; Borchers S; Figueiredo C; Jacobs R; Sundarasetty BS; Schneider A; Schambach A; Eiz-Vesper B; Blasczyk R; Weissinger EM; Ganser A; Stripecke R
    Vaccine; 2012 Jul; 30(34):5118-31. PubMed ID: 22691433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.